Filing Details

Accession Number:
0001181431-13-030751
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-24 17:50:51
Reporting Period:
2013-05-22
Filing Date:
2013-05-24
Accepted Time:
2013-05-24 16:50:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534287 Bioamber Inc. BIOA.U Industrial Organic Chemicals (2860) 980601045
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1250264 W Kurt Briner 10 Avenue De Grand Bretagne
O9 98000
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-22 7,000 $0.00 7,000 No 4 P Direct
Common Stock Acquisiton 2013-05-23 6,000 $0.00 13,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2013-05-22 7,000 $0.00 3,500 $0.00
Common Stock Common Stock Warrants (right to buy) Acquisiton 2013-05-23 6,000 $0.00 3,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,000 2013-08-08 2017-05-09 No 4 P Direct
13,000 2013-08-08 2017-05-09 No 4 P Direct
Footnotes
  1. The reported securities are included within 7,000 Units acquired by the reporting person on May 22, 2013 for $8.0955 per Unit in an open market purchase. Each Unit consists of one share of common stock and one warrant to purchase half of one share of common stock. The Units currently trade on the NYSE. The common stock and warrants comprising the Units will begin trading separately on June 10, 2013, at which time trading of the Units will be suspended and the Units will be de-listed. Each warrant will be exercisable during the period commencing on August 8, 2013 and ending at 5:30 p.m. on May 9, 2017 at an exercise price of $11.00 per whole share of common stock.
  2. The reported securities are included within 6,000 Units acquired by the reporting person on May 23, 2013 for $8.2850 per Unit in an open market purchase. Each Unit consists of one share of common stock and one warrant to purchase half of one share of common stock. The Units currently trade on the NYSE. The common stock and warrants comprising the Units will begin trading separately on June 10, 2013, at which time trading of the Units will be suspended and the Units will be de-listed. Each warrant will be exercisable during the period commencing on August 8, 2013 and ending at 5:30 p.m. on May 9, 2017 at an exercise price of $11.00 per whole share of common stock